Introduction
Inaccurate results can occur in clinical diagnostic assays due to addition of insufficient sample to the reaction mixture, or improper dilution of sample. The result of this type of error is under recovery of analyte and is often referred to as a "short sample." These types of errors are usually caught by inspection of data by technicians, delta check analysis, or other data checking algorithms. However, even today, the most sophisticated analyzers cannot reliably detect short samples.
The Piccolo ® Point-of-Care Chemistry Analyzer performs analysis of test panels contained in reagent discs.The system performs the functions of separating the sample into the plasma and the cellular components, measures the volume of plasma needed for analysis, measures a volume of diluent, mixes them, and delivers this aliquot to the reaction cuvettes, where the reagents are present in freeze-dried form.The system allows a complete panel of tests to be performed on the same diluted sample.
We have developed an algorithm to detect short samples by evaluating results from numerous analytes.The algorithm is based on the population distribution from over 16,000 test panels containing these analytes.The algorithm makes use of the probability distribution for several analytes in a panel, not just one or two.
The challenge for developing such an algorithm is to find the cut off threshold that permits detection of true short samples and can differentiate these from samples where the patient's results are low, but correct.
While this algorithm was developed for use with the Piccolo ® analyzer, it has broad applications to other automated systems where test panels are run.
Methods
• Testing of a population of patients using an Olympus AU640 and the manufacturer's reagents and methods • Piccolo discs specifically manufactured to give a high incidence of "short samples"
• Diluted whole blood and serum samples
Abstract
The ABAXIS Piccolo ® point-of-care analyzer is a compact and lightweight analyzer capable of measuring up to 14 analytes from a single 90 microliter sample.The ABAXIS Piccolo ® point-of-care analyzer can run a variety of standard CMS panels, including the 14-analyte Comprehensive Metabolic Panel, the 8-analyte Basic Metabolic Panel and the 7-analyte Hepatic Function Panel. One drawback common in all analyzers is the issue of "short sample."Although clinical analyzers typically aspirate and dilute samples very precisely, and phlebotomists normally take great care in sample collection, human and machine errors can occur, resulting in incorrect test results. Fibrin may form in the sample probe or distribution channels of an analyzer, or a sample may be diluted by IV fluid.The measurement of short samples and diluted samples is a source of medical errors.These types of samples are normally very difficult to detect in analyzers and can have devastating consequences in the diagnosis and monitoring of patients. Currently there are no reliable and simple methods to detect the presence of short or diluted samples. Current tools used to identify short or diluted samples include delta-checking methods and abnormal/ critical value limit checks.
We have developed a short sample algorithm for the Piccolo ® point-of-care analyzer.This algorithm is based on statistical analysis of analyte distributions from over 16,000 patients and can detect short samples and sample dilutions corresponding to as low as 5% insufficient sample volume or over-dilution of sample.This algorithm utilizes the population distributions from the multiple analytes available on Piccolo ® rotors and is more robust than short sample techniques based on single analyte distributions or analyte distributions within a single class of analytes, such as electrolytes. Data has been evaluated showing the use of this algorithm with four different Piccolo ® rotors in a clinical setting as well as in a controlled setting where deliberate short samples and sample dilutions were evaluated.
Results for the Comprehensive Metabolic Panel Piccolo
® rotor are shown in Table 1 .These were simulated short samples from actual clinical samples.The last column shows the percent dilution required to trigger the short sample warning. In actual clinical testing, all verified short samples were detected with no false positives.
This algorithm can be used as a useful tool to help ensure the integrity of results, particularly in a point-of-care setting where extensive oversight of results may not be available. 
Procedure
• We established the "frequency distribution"of analytes for a large population hospital-based patient samples that encompassed a large spectrum of test values, and calculated the probability of finding a particular value.
• We examined the statistical characteristics of a panel of analytes and defined a mathematical function that will maximize the sensitivity of the algorithm to the presence of short samples.
• We assayed a large number of samples where the same test panel is measured and determine the cumulative distribution of the probability of a short sample.
• The cumulative distribution of a particular panel allows selection of the probability value to be used as the threshold for the flagging of results from short samples. By statistical analysis the number of false positives or false negatives can be determined.
• The measurement results from any sample can be used to simulate the effect of short samples on the probability by simply diluting that sample appropriately. By testing dilutions of samples with a significant range of analyte values, the decision threshold for flagging the results for any acceptable level of dilution can be fine-tuned. Results (cont.) 
Results

